🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.7290
-0.0400 (-5.20%)
Nov 20, 2026, 5:29 PM CET

IRLAB Therapeutics AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
90.6481.8666.92111.31252.78401.9
Cash & Short-Term Investments
90.6481.8666.92111.31252.78401.9
Cash Growth
-17.70%22.33%-39.88%-55.96%-37.10%45.08%
Accounts Receivable
13.97---3.324.47
Other Receivables
-3.3210.089.178.96.27
Receivables
13.973.3210.089.1712.2210.74
Prepaid Expenses
-2.912.192.83.342.28
Other Current Assets
-0.380.370.310.356.52
Total Current Assets
104.6188.4779.56123.59268.68421.44
Property, Plant & Equipment
2.395.479.796.678.018.35
Other Intangible Assets
46.8646.8646.8646.8646.8642.4
Long-Term Deferred Charges
-----0.26
Other Long-Term Assets
00-0--0-0
Total Assets
153.86140.8136.21177.12323.56472.45

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
-5.299.9410.5210.0312.3
Accrued Expenses
-14.0811.6814.9113.445.84
Short-Term Debt
-26.4253.47---
Current Portion of Leases
0.913.543.422.943.63.03
Current Unearned Revenue
-----42.58
Other Current Liabilities
55.7760.7721.548.355.285.65
Total Current Liabilities
56.67110.09100.0436.7332.3469.4
Long-Term Debt
17.03--24.51--
Long-Term Leases
--3.540.120.383.57
Other Long-Term Liabilities
-0-----
Total Liabilities
73.7110.09103.5861.3632.7272.97

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2.971.71.041.041.041.04
Additional Paid-In Capital
871.84800.41690.21690.21690.21685.45
Retained Earnings
-794.65-771.39-658.61-575.48-400.41-287
Comprehensive Income & Other
--0---
Shareholders' Equity
80.1630.7232.64115.76290.83399.48
Total Liabilities & Equity
153.86140.8136.21177.12323.56472.45

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
17.9429.9560.4227.573.986.6
Net Cash (Debt)
72.7151.916.583.74248.8395.3
Net Cash Growth
-9.49%699.06%-92.24%-66.34%-37.06%44.23%
Net Cash Per Share
0.730.770.131.614.807.64
Filing Date Shares Outstanding
142.6284.9451.8751.8751.8751.75
Total Common Shares Outstanding
142.6284.9451.8751.8751.8751.75
Working Capital
47.94-21.62-20.4886.86236.34352.04
Book Value Per Share
0.560.360.632.235.617.72
Tangible Book Value
33.3-16.14-14.2368.9243.97357.08
Tangible Book Value Per Share
0.23-0.19-0.271.334.706.90
Machinery
---6.826.533.65
Leasehold Improvements
-7.147.140.120.120.12